Invasive ventilation and mortality in critically ill nonagenarians: a retrospective cohort study
Open Access
- 28 January 2026
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Abstract
Background: ICU admissions among very old patients are increasing. Invasive ventilation (IV) is common, but its benefit in patients aged ≥ 90 years is uncertain given high mortality and ethical concerns. Methods: This retrospective cohort study analysed all consecutive ICU patients aged ≥ 90 years admitted between 2008 and 2023 at a tertiary care centre in Germany. Demographic, clinical, and outcome data were extracted from electronic health records. Multivariable logistic regression was used to identify predictors of hospital mortality, while Kaplan–Meier survival analysis and Cox proportional hazards regression were used to assess predictors of 1-year mortality. Results: Of 113,950 patients, 1422 (1.25%) aged ≥ 90 years were identified (median 92 years, IQR 91–94; 66% female). IV was administered to 434 patients (31%), while 988 (69%) were not invasively ventilated. Median ICU length of stay was 1.7 days (IQR 1–4) overall. Among ventilated patients, the median duration of IV was 13 h (IQR 4–44), and 66% received IV for less than 24 h. IV was associated with higher illness severity at admission (SOFA score 9 [IQR 7–11] vs. 2 [IQR 1–4], p < 0.001), longer ICU stays (2.9 days [IQR 1.1–7.4] vs. 1.5 days [IQR 0.9–3.1], p < 0.001), as well as higher requirement of vasopressors at admission (0.112 µg/kg/min [IQR 0.056–0.278] vs. 0.072 µg/kg/min [IQR 0.038–0.133], p < 0.001) and renal replacement therapy (3.5% [n = 15] vs. 1.7% [n = 17], p = 0.042). In patients requiring IV, ICU and hospital mortality were 35.7% (n = 155) and 49.3% (n = 214) vs. 11.5% (n = 114) and 21.5% (n = 212) in non-IV patients, respectively (both p < 0.001). Independent and significant predictors of hospital mortality included prolonged IV duration (> 72 h: OR 4.01), peak lactate ≥ 4 mmol/l within 72 h (OR 6.67), as well as elevated SOFA scores (4–7: OR 1.96, ≥ 8: OR 3.46), and CCI ≥ 3 (OR 1.74) at admission. One-year mortality risks were 73.2% (95% CI 68.5–77.3%) and 53.4% (95% CI 50.0–56.6%) for IV and no-IV patients (p < 0.001), respectively. Conclusions: In this selected cohort of ICU patients aged ≥ 90 years, invasive ventilation–particularly beyond 72 h–identified a subgroup with very high ICU and hospital mortality and greater illness severity. These observational data support using invasive ventilation in nonagenarians as a trigger for early, patient-centred goals-of-care discussions, rather than as evidence that ventilation itself causes excess mortality.Keywords
Funding Information
- Universitätsklinikum Hamburg-Eppendorf (UKE)
This publication has 29 references indexed in Scilit:
- Use of Mechanical Ventilation Across 3 CountriesJAMA Internal Medicine, 2023
- End-of-life practices in 11 German intensive care unitsMedizinische Klinik - Intensivmedizin und Notfallmedizin, 2022
- The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 studyIntensive Care Medicine, 2019
- Premorbid functional status as a predictor of 1-year mortality and functional status in intensive care patients aged 80 years or olderIntensive Care Medicine, 2018
- The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysisIntensive Care Medicine, 2017
- Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregiversIntensive Care Medicine, 2016
- The ETHICA study (part I): elderly’s thoughts about intensive care unit admission for life-sustaining treatmentsIntensive Care Medicine, 2013
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987